Study Stopped
insufficient recruitment
Cognitive Control and Physical Exercise
2 other identifiers
interventional
12
1 country
1
Brief Summary
The purpose of this study is to test the hypothesis that aerobic exercise and a computer-based cognitive intervention leads to improved cognitive function accompanied by increases in gray matter density and changes in functional magnetic resonance imaging (fMRI) patterns of task-related activation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 16, 2010
CompletedFirst Posted
Study publicly available on registry
August 18, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedAugust 5, 2015
August 1, 2015
5.3 years
August 16, 2010
August 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in measures of executive control function and episodic memory at 6 months
tests of global intelligence, executive function, working memory and processing speed
Baseline and 12 weeks
Secondary Outcomes (3)
Changes in brain structure, resting cerebral blood flow and network efficiency at 6 months
Baseline and 12 weeks
Change in aerobic capacity at 6 months
Baseline and 12 weeks
Changes in measures of executive control function and episodic memory at 1 year
Baseline and 52 weeks
Study Arms (3)
Space Fortress and Exercise
EXPERIMENTALParticipants engage in aerobic exercise 4 times week and Space Fortress sessions 3 times a week for a total of 12 weeks.
Control Games and Exercise
ACTIVE COMPARATORParticipants engage in aerobic exercise 4 times a week and control game sessions 3 times a week for a total of 12 weeks.
Control Games and Stretching
ACTIVE COMPARATORParticipants engage in stretching/toning exercises 4 times a week and control game sessions 3 times a week for a total of 12 weeks.
Interventions
Space Fortress sessions 3 times a week for 12 weeks
Aerobic Exercise 4 times a week for 12 weeks
Stretching/Toning exercise 4 times a week for 12 weeks.
Control games session 3 times a week for 12 weeks
Eligibility Criteria
You may qualify if:
- Age 60-75
- English-speaking
- Strongly right-handed
- BMI \> 18.5 and \< 32
- Post-menopausal (women only): no estrogen replacement therapy
- Sedentary: VO2max \< 36 ml/kg/min for men age 60-75; \< 29 ml/kg/min for women age 60-75 (determined using Jones Formula Men = (60-(0.55\*AGE)) Women = (48-(.37\*AGE))
You may not qualify if:
- MRI contraindications (e.g., metallic implants, pacemaker, weight \> 350 lbs, waist \> 55")
- Hearing impaired/hearing aids, unable to read newspaper at arm's length with corrective lenses
- Objective cognitive impairment
- Ischemic changes, abnormal blood pressure responses, or any significant ectopy during aerobic capacity testing
- Cardiovascular disease
- Uncontrolled high blood pressure (systolic blood pressure ≥ 180 mmHg; or diastolic blood pressure ≥ 105 mmHg on two measures)
- Current or recent (evidence of disease x 5 years) non-skin neoplastic disease or melanoma
- Active hepatic disease (not a history of hepatitis) or primary renal disease requiring dialysis, primary untreated endocrine diseases, e.g., Cushing's disease or primary hypothalamic failure or insulin dependent diabetes (Type I or II).
- HIV infection
- Pregnant or lactating (participation allowed 3 months after ceasing lactation
- Other medical disorders judge to interfere with study
- Medications that target CNS (e.g., neuroleptics, anticonvulsants, antidepressants, benzodiazepines) within the last month
- Women: any selective estrogen receptor modulator or aromatase inhibitor Men: androgen ablation/deprivation hormonal therapies
- Any history of psychosis or electroconvulsive therapy
- Psychotic disorder (lifetime)
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Columbia University Medical Center
New York, New York, 10032, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yaakov Stern, Ph.D.
Sergievsky Center Columbia University Medical Center
- PRINCIPAL INVESTIGATOR
Richard Sloan, Ph.D.
Behavioral Medicine Columbia University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Clinical
Study Record Dates
First Submitted
August 16, 2010
First Posted
August 18, 2010
Study Start
February 1, 2010
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
August 5, 2015
Record last verified: 2015-08